Attached files
| file | filename |
|---|---|
| EX-10.17 - AMENDMENT TO AMENDED AND RESTATED EMPLOYMENTAGREEMENT, DATED OCTOBER 29, 2018, B - ORAMED PHARMACEUTICALS INC. | f10k2018ex10-17_oramedpharma.htm |
| EX-32.2 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2018ex32-2_oramedpharma.htm |
| EX-32.1 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2018ex32-1_oramedpharma.htm |
| EX-31.2 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2018ex31-2_oramedpharma.htm |
| EX-31.1 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2018ex31-1_oramedpharma.htm |
| EX-10.24 - REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTSBETWEEN ORAMED PHARMACEUTICALS - ORAMED PHARMACEUTICALS INC. | f10k2018ex10-24_oramedpharma.htm |
| EX-10.18 - EMPLOYMENT AGREEMENT, DATED NOVEMBER 6, 2018,BY AND BETWEEN ORAMED LTD. AND MARK - ORAMED PHARMACEUTICALS INC. | f10k2018ex10-18_oramedpharma.htm |
| 10-K - ANNUAL REPORT - ORAMED PHARMACEUTICALS INC. | f10k2018_oramedpharma.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-215525 and 333-190497) and Form S-8 (Nos. 333-213835, 333-199120, 333-190222 and 333-163919) of Oramed Pharmaceuticals Inc. of our report dated November 27, 2018 relating to the financial statements, which appears in this Form 10-K.
| Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
| November 27, 2018 | Certified Public Accountants (lsr.) |
| A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,
P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il